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ABSTRACT 
Purpose. For patients with chronic hepatitis due to hepatitis B virus (HBV), factors predicting 
hepatocellular carcinoma (HCC) other than high levels of HBV DNA and aminotransferase (ALT) are 
needed to prevent HCC development, as many patients with chronic HBV infection fulfill these 
conditions. The purpose of this study was to clarify factors predictive of HCC development for those 35 
patients. 
Methods. The study was a systematic cohort analysis of 303 consecutive patients with hepatitis B 
e-antigen, receiving laparoscopic examination for assessment of liver disease. Laparoscopic, 
histological, and clinical characteristics were investigated as related to HCC development. 
Results. HCC occurred in 27 patients during a mean follow-up of 8.0  5.0 years, at the age of 37-72 40 
years. Significant associations with HCC development were shown for liver cirrhosis, histological 
activity grade, reddish markings, and older age. Multivariate analysis revealed that HCC development 
was strongly associated with older age and male gender (P=0.002 and P=0.043, respectively). HCC 
occurred more frequently in patients of age 30 years even with early stage than in patients of age <30 
years (p=0.031). Severe reddish markings, a laparoscopic finding of widespread parenchymal 45 
destruction, were highly associated with HCC development in patients of age 30 years at diagnosis 
(odds ratio=1.67, P=0.034), while histological activity grade and ALT level were not (P=0.075, and 
P=0.69, respectively).  
Conclusions. HCC development is associated with older age, male gender, and liver cirrhosis. 
Reddish markings, rather than histological activity or ALT level, can be useful to predict HCC for HBV 50 
patients of age 30 years. 
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INTRODUCTION 55 
Hepatitis B virus (HBV) is distributed worldwide, and 400 million people suffer from chronic hepatitis B 
infection (1). Hepatocellular carcinoma (HCC) and liver failure are frequent among patients with HBV 
infection. The incidence of HCC development is estimated at 0.8% annually, approximately 100-fold 
higher than the rate among uninfected people. Half a million patients die of liver-related causes every 
year (2). Several studies of the prognosis of HBV have shown that persistent elevation of HBV-DNA 60 
and alanine aminotransferase (ALT) in serum are highly associated with rapid disease progression and 
HCC development (3, 4). Host factors such as age, gender, and alcohol intake, and viral factors 
including hepatitis B e-antigen (HBeAg) and HBV genotype have been implicated as important 
contributors to disease progression. In Japan, HBV genotype C is predominant over other genotypes, 
and most HBV patients with chronic hepatitis have been infected perinatally or during early childhood 65 
(5). Recent reports have indicated that HBV genotype C is related to poor outcome of slower HBeAg 
seroconversion (6), earlier disease progression, and more frequent HCC development (7).  
Good control of viral replication with nucleoside analogues can decrease liver inflammation 
and reduce the risk of poor outcomes (8). Such drugs may work, in the short term at least, for most 
patients in the immune-active phase of chronic HBV infection. However, benefits for long-term survival 70 
have not been well-defined. Some patients in young or middle age hesitate to use these drugs due to 
the possibility of drug resistance and the high cost for medication for life-long use. The presence of 
HBeAg often indicates active viral replication, and high levels of ALT in the immune-active phase; 
many patients with HBeAg are thus suitable candidates for use of nucleoside analogues. Predictors for 
rapid progression to liver cirrhosis and high risk of HCC development should be more clearly defined, 75 
to facilitate the selection of HBeAg-positive patients who should be treated immediately with 
nucleoside analogues.  
 Laparoscopy provides wide and precise observation of the liver surface. Kalk reported 
morphological progression from acute hepatitis to cirrhosis (9, 10). Laparoscopic observation with liver 
biopsy is considered the most accurate method of evaluating liver cirrhosis (11-14). Besides 80 
usefulness in evaluating present disease progression, direct observation of the liver surface can 
provide a large amount of information on disease activity, capsular structural changes, and small 
lesions on the surface, which can be difficult or impossible to detect on ultrasonography or computed 
tomography. Studies of patients with hepatitis C virus (HCV) have proposed the importance of 
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laparoscopic examination and have noted that irregular regenerative nodules, degree of regenerative 85 
nodules, and atrophic right lobe can be observed clearly by laparoscopy, and also that those findings 
represent independent risk factors for HCC development (15, 16). Associations with laparoscopic 
features have not been well-defined for HBV patients with regard to HCC development.  
 The purpose of this study was to clarify useful predictive factors of HCC development for HBV 
patients with HBeAg, by evaluating laparoscopic features, clinical characteristics, and histology with 90 
regard to the development of HCC. We revealed that liver cirrhosis, older age, male gender, and a 
laparoscopic feature of reddish markings were strongly associated with HCC development, and 
proposed the importance of laparoscopic examination to evaluate the risk of HCC development.  
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PATIENTS AND METHODS 95 
Patients 
This study was a systematic cohort analysis of 303 consecutive patients with HBeAg, and who 
underwent laparoscopic examination and liver biopsy for the assessment of chronic liver injury at 
Okayama University Hospital between 1982 and 2002. Presence of HCC was excluded in all patients 
by imaging examinations with abdominal ultrasonography and computed tomography and by showing 100 
normal values of alpha-fetoprotein in serum at the time of diagnosis. Patients suffering from acute 
hepatitis due to HBV, those with serum positivity for anti-HCV antibodies, and those with daily ethanol 
intake of >75 g were excluded from the study. The study was performed in accordance with the 
Helsinki Declaration, and all protocols were approved by the ethics committees of the involved 
institutes. All patients provided informed consent before enrolment into the study.  105 
 
Scoring of liver function by using laboratory parameters 
In order to estimate the usefulness of laboratory parameters to assess liver function, we selected 5 
conventional parameters, and evaluated the score based on these values with histological fibrosis 
stage. These parameters were scored according to the normal ranges in our institutes as follows: 110 
prothrombin time (0, >80%; 1, ≤80%); platelet count (0, >15 104/mm3; 1, ≤15 x104/mm3); serum level 
of albumin (0, >3.9 g/dl; 1, ≤3.9 g/dl); serum level of total bilirubin (0, <1.2 mg/dl; 1, ≥1.2 mg/dl); and the 
ratios of aspartate aminotransferase (AST) and ALT (0, <1.0; 1, ≥1.0).  
 
Histological evaluation 115 
Stage of histological fibrosis and grade of activity were assigned by two pathologists according to the 
criteria of Desmet et al. (17). All biopsy specimens were obtained under laparoscopic guidance and 
were more than 1.5 cm long and 2 mm wide. The amount of obtained material was therefore adequate 
for histological evaluation.  
 120 
Laparoscopic examination 
We selected the following six features for analysis, because these are routinely used for evaluation of 
disease progression and activity: surface irregularity, whitish markings, vascular proliferation, reddish 
markings, patchy markings, and fat deposition (18-21). Surface irregularity was evaluated, based on 
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depression and nodular formation, and classified into three stages: S1, normal or early stage; S2, 125 
advanced, pre-cirrhotic stage; and S3: cirrhotic stage. Reddish markings were scored according to 
location, distribution and color tone of the markings. Whitish markings were defined with their location. 
These features were assessed as mild or severe based on the total scores as in Table 1. As for 
vascular proliferation, dilated peripheral portal veins are often observed on liver surface of the patients 
with chronic hepatitis, and small arteries may become visible when the disease has been progressed. 130 
We graded dilated peripheral portal veins as mild and proliferation of small arteries as severe for 
vascular proliferation. These classifications have been used since Shimada et al. reported their 
usefulness in 1971 to evaluate disease activity and to predict disease progression for chronic hepatitis 
(18). Several reports from different institutes have proposed similar classifications by using these 
features, and revealed these importances for evaluation of disease progression (16, 22, 23). Final 135 
laparoscopic findings were evaluated independently by three experienced hepatologists (S.F., B.S., 
and K.Y.), and discussed for final diagnosis. Figure 1 shows typical laparoscopic features of the liver 
surface. 
 
Follow-up 140 
All patients received medical check-ups with blood examinations every 2-3 months, and abdominal US 
or CT every 6 months at least as recommended (24, 25). Patients who had not visited our hospital in 
the previous 6 months were contacted by letter or telephone and asked to provide details of recent 
medications by questionnaires. If they visited other hospitals, we also asked them about the results of 
any imaging studies. For cases in which the patient had died, the date and cause of death were 145 
recorded. No patients were treated with nucleoside analogues during follow-up. 
 
Statistical analysis 
Data are expressed as mean ±standard deviation (SD) or median (range). Patient laboratory data and 
laparoscopic findings were compared with histological findings using the Kruskal-Wallis test and 150 
canonical correlation analysis. Proportional hazards models were utilized to estimate the effects of 
patient characteristics on HCC development. Incidence rates of HCC were estimated using the 
Kaplan-Meier method, and compared with the log-rank test. A value of P<0.05 was considered 
significant. Statistical analysis was performed with JMP software (SAS Institute, Cary, NC). 
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RESULTS 155 
Patient characteristics 
Table 2 lists the clinical characteristics of patients enrolled in this study. Mean age of patients was 34 
11 years, and 232 patients were male (76.6%). Of the patients, 71.6% had some family history of liver 
disease. In order to estimate the usefulness of laboratory parameters to assess liver function, we 
selected 5 conventional parameters, and compared the scores based on these values with histological 160 
fibrosis stage (Fig. 2a). Surprisingly, only half of the patients with a total score of 0 (49.1%), 
representing completely normal in this scoring system, were histologically defined as early stage 
(fibrosis stage 0 or 1), and 20.5% were advanced, at the pre-cirrhotic or cirrhotic stage (fibrosis stage 3 
or 4). These results indicate the necessity for liver biopsy, as conventional laboratory parameters 
cannot distinguish patients in the early stage from those in the advanced stages, although total scores 165 
of laboratory data correlated significantly with stages of histological fibrosis (R=0.46, P<0.0001, 
canonical correlation analysis). In terms of activity grades, mean ALT levels in patients were very high 
(156  142 IU/l), and 51.9% of patients with histological grade A1 showed ALT levels ≥80 IU/l (Fig. 2b). 
ALT levels displayed weak associations with histological activity grade (R=0.14, P=0.013).  
 170 
Laparoscopic findings at the time of diagnosis 
Table 3 provides a summary of laparoscopic features. Frequencies were calculated for each group of 
surface irregularity. Reddish markings and patchy markings were frequently observed in S2 (74% and 
72%, respectively, P<0.001 each). Vascular proliferation was observed less in S2 (73%) than in S1 
(86%) or S3 (87%, P=0.018, Kruskal-Wallis tests). Severe vascular proliferation, reflecting proliferation 175 
of small arteries was more frequently observed in S3 than S1 or S2, although this increase was not 
statistically significant (P=0.84). Whitish markings tended to be less frequent, and fat deposition more 
frequent in S3 than in S1 or S2, but no significant differences were identified (P=0.31 and P=0.061, 
respectively). Correlations between histological fibrosis stage and laparoscopic surface irregularity 
were significantly strong (R=0.71, P<0.0001, canonical correlation analysis; Fig. 2c). Reddish 180 
markings were significantly associated with histological activity grade as shown in Fig. 2d (R=0.45, P 
<0.0001). 
 
Risks of HCC development 
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HCC development was evaluated for 250 patients who were observed for 1 year. The accumulated 185 
observation was 1991 person-years, accounting for 80% of the total potential follow-up. HCC 
developed in 27 patients during a mean follow-up period of 8.0  5.0 years, at the age of 37-72 years. 
The incidence of HCC development was estimated as 5.7% at 5 years of follow-up, 13.5% at 10 years, 
and 20.6% at 15 years (Fig 3a). Fig. 3b shows cumulative rates of HCC development by age, 
estimated as 1.3% at 40 years old, 12.3% at 50 years old, and 27.2% at 60 years old. When the 190 
patients were divided in three groups according to age at diagnosis (<30 years, 31-39 years, and 40 
years), there were significant differences in cumulative rates of HCC development among the groups 
(P=0.003, log-rank test, Fig. 3c), especially between the age groups <30 years, and 30 years 
(P=0.0009, log-rank test). The patient groups of age 31-39 years and age 40 years were estimated to 
have similar risks of HCC occurrence (P=0.57, log-rank test). Furthermore, male patients showed a 195 
higher risk of HCC development than females (P=0.008, log-rank test, Fig. 3d), as previously reported 
(1-7). Table 4 shows evaluations of clinical characteristics, histology, and laparoscopic features, with 
regard to HCC development using proportional hazards models. Significant associations with HCC 
development were shown for liver cirrhosis according to histological fibrosis and laparoscopic surface 
irregularity, high histological activity grade, laparoscopic severe reddish markings, and older age at 200 
diagnosis in univariate analysis. Cumulative risks of HCC development were also estimated by the 
Kaplan-Meier method (Fig. 4). Severity of reddish markings correlated significantly with risk of HCC 
development (P=0.036, log-rank test), while histological activity grade did not (P=0.054), suggesting 
some difference between these two parameters. Multivariate analysis, adjusted with a logistic 
likelihood ratio test, revealed that HCC development was strongly associated with older age and male 205 
gender (P=0.002 and p=0.043, respectively). Laparoscopic surface irregularity was not used for 
multivariate analysis, due to high correlations of laparoscopic surface irregularity with histological 
fibrosis stage as shown in Fig. 2c.  
 
Sub-group analysis for HCC development 210 
Next, we studied age difference by dividing patients according to age at diagnosis (<30 years, and 30 
years), and our results in proportional hazards models showed that advanced stages according to 
histological fibrosis stage and surface irregularity were significantly associated with HCC development 
for patients of age 30 years at diagnosis (P=0.040, and P=0.016, respectively, Table 5). Severe 
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inflammatory activity with reddish markings also affected HCC development (P=0.034). Therefore we 215 
estimated cumulative rates of HCC development, by using the Kaplan-Meier method. Among patients 
of age 30 years at diagnosis, cumulative rates of HCC development were higher in more advanced 
disease, according to surface irregularity (Fig. 5b, P=0.043, log-rank test). Cumulative rates of HCC 
development was 37.1% at the 10-year follow-up among the patients in cirrhotic S3 stage, 25.6% 
among those in pre-cirrhotic S2 stage, and 10.1% among those in S1 stage. Interestingly, the risk of 220 
HCC occurrence was significantly higher for those in as early as S1 stage, compared with the patients 
of age <30 years (Fig. 5c, P=0.031, log-rank test). Actually, none of age <30 years experienced HCC 
during the 10-year follow-up. Further sub-group analysis in those of age 30 years in each 
laparoscopic stage could not find any significant factors contributing to HCC development. As for the 
effects of inflammatory activity on HCC development, significant differences in cumulative rates of 225 
HCC development were observed among the patients of age  30 years at diagnosis when stratified by 
reddish markings (Fig.6, P=0.025, log-rank test), but not by histological activity (P=0.087) or ALT levels 
(P=0.69).  
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DISCUSSION 230 
Persistent elevation of HBV-DNA and ALT are associated with rapid disease progression and HCC 
development (3, 4). Most patients with HBeAg might be candidates for treatment with nucleoside 
analogues, as the presence of HBeAg often indicates active viral replication and high levels of ALT in 
an immune-active state of chronic infection. However, due to drug resistance and the high cost of 
life-long medication, predictors for HCC development should be more clearly defined so that patients 235 
can judge the necessity of immediate treatment using nucleoside analogues. We hypothesized that 
laparoscopic observation of the liver surface might work for this purpose. The present study 
retrospectively evaluated long-term outcomes for a large systematic cohort of HBeAg-positive patients, 
focusing on HCC development, using laparoscopic, histological, and clinical characteristics.  
In the present study, half patients with early-stage (S1) disease were <30 years old at 240 
diagnosis. Cumulative rate of HCC development was 0.0% during the following 10 years, partly 
because some patients showed seroconversion to negative HBeAg in the following 10 years with 
cessation of hepatitis. Conversely, the patients who were 30 years old in the early stage showed a 
significantly higher risk of HCC, compared to the patients of age <30 years. Treatment with nucleoside 
analogues may be worth considering in such patients, although incidence rates were less than those of 245 
patients in the pre-cirrhotic stage or cirrhotic stage. Age differences in disease progression have been 
reported with other chronic liver diseases, including chronic hepatitis C (26), autoimmune hepatitis (27), 
and primary biliary cirrhosis (28). Our results suggest that age difference plays some role in HCC 
development among HBV patients, and that patients of age <30 years should be re-evaluated with liver 
biopsy within 10 years if HBV-DNA and ALT levels remain elevated.  250 
Interestingly, our analysis of the patients of age 30 years revealed that a laparoscopic finding 
of reddish markings correlated significantly with HCC development. Reddish markings were 
significantly correlated with histological activity, but these parameters showed different influences on 
HCC development. This was suspected to arise from differences in the origins of these parameters. 
Ohta et al. performed precise histological analysis of reddish markings with histological reconstruction 255 
using serial sections of liver biopsy specimens from cases with reddish markings (22). They revealed 
that reddish markings correspond to widespread necrosis of hepatocytes, and proposed this finding as 
a useful index of activity in chronic hepatitis. Shibayama et al. showed that reddish markings did not 
appear in the early stage of chronic hepatitis with piecemeal necrosis around the portal area, instead 
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appearing only after hepatic parenchymal destruction subjacent to the liver capsule due to prolonged 260 
active hepatitis or repeated acute exacerbations of chronic hepatitis (16, 23). Reddish markings as an 
index of laparoscopic activity are not equivalent to piecemeal necrosis as an index of histological 
activity. Progression to liver cirrhosis may occur after the appearance of reddish markings unless the 
activity of chronic hepatitis can be reduced, because hepatic parenchymal destruction may change the 
pattern of blood flow in the liver to an increasingly cirrhotic pattern. Reddish markings might be useful 265 
not for early detection of HCC, but as warning of transition to liver cirrhosis prior to HCC development. 
Our results indicate reddish markings as a useful predictor of HCC development. 
In terms of liver cirrhosis, our results are consistent with previous reports, showing that liver 
cirrhosis in histological fibrosis or laparoscopic surface irregularity is strongly associated with HCC 
development (14). This strong association might explain the results of subgroup analysis among 270 
cirrhotic patients, in which no significant predictive factors could be found for HCC development. This 
reveals that HCC might occur irrespective of other conditions such as liver inflammation, once liver 
disease has progressed to cirrhosis. Actually, the role of antiviral therapy with nucleoside analogues 
has not been well-defined for cirrhotic patients with regard to reduced HCC development. We have 
previously reported that cumulative recurrence rates of HCC after initial and complete treatment for 275 
HCC did not differ between lamivudine-treated and control groups (29). Kuzuya et al. supported this 
finding and suggested that antiviral therapy may improve remnant liver function and increase the 
chances of receiving available treatment modalities for recurrent HCC (30).  
Completely normal values from routine laboratory tests of liver function might suggest a 
normal liver or only early-stage liver disease, but our analysis showed that only half of patients with 280 
such completely normal values were in the early stage. Several investigators have reported 
noninvasive approaches for quantitative diagnosis of liver fibrosis, using routine laboratory tests, 
serum fibrosis markers, radiological imaging, and elastography (31), all of which have been in practical 
use for hepatitis C. Prolonged active hepatitis or repeated acute exacerbations may occur frequently in 
HBV patients, and might disturb the accuracy of noninvasive quantitation of liver fibrosis (32). Liver 285 
biopsy appears warranted for precise evaluation of disease progression, and further examination with 
laparoscopy would be ideal, even if liver function tests continue to yield normal results.  
In conclusion, HCC development is associated with older age, male gender, and liver cirrhosis. 
Reddish markings, rather than histological activity or ALT level, can be useful to predict HCC for HBV 
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patients of age 30 years at diagnosis. Patients of age 30 years even in the early stage may consider 290 
treatment with nucleoside analogues because of relatively high risk of HCC development. 
 Shoji et al. Laparoscopy of HBV to predict HCC  - 13 - 
REFERENCES 
1. Beasley RP, Hwang LY, Lin CC, et al. Hepatocellular carcinoma and hepatitis B virus. A 
prospective study of 22 707 men in Taiwan. Lancet 1981;2:1129-1133. 
2. Liaw YF, Tai DI, Chu CM, et al. Early detection of hepatocellular carcinoma in patients with 295 
chronic type B hepatitis. A prospective study. Gastroenterology 1986;90:263-267. 
3. Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on 
disease progression and prognostic factors. J Hepatology 2008;48:335-352. 
4. Tong MJ, Hsien C, Hsu L, et al. Treatment recommendations for chronic hepatitis B: an 
evaluation of current guidelines based on a natural history study in the United States. Hepatology 300 
2008;48:1070-1078. 
5. Lai CL, Lok AS, Lin HJ, et al. Placebo-controlled trial of recombinant alpha 2-interferon in 
Chinese HBsAg-carrier children. Lancet. 1987;2:877-880. 
6. Orito E, Ichida T, Sakugawa H, et al. Geographic distribution of hepatitis B virus (HBV) 
genotype in patients with chronic HBV infection in Japan. Hepatology. 2001;34:590-594. 305 
7. Sumi H, Yokosuka O, Seki N, et al. Influence of hepatitis B virus genotypes on the progression 
of chronic type B liver disease. Hepatology. 2003;37:19-26. 
8. Yang HI, Lu SN, Liaw YF, et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. 
N Engl J Med. 2002;347:168-174. 
9. Kalk H. Dienchronishen Verlaufsformen der Hepatitis epidemica in Beziehung zu ihren 310 
anatomischen Grudlagen. DMW 1947;72:308-313. 
10. Kalk H, Wildhirt E. Lehrbuch und Atlas der Laparoskopie and Leberpunction. Georg Thieme 
Verlag,Stuttgart, 1962. 
11. Poniachik J, Bernstein DE, Reddy KR, et al. The role of laparoscopy in the diagnosis of 
cirrhosis. Gastrointest Endosc. 1996;43:568-571. 315 
12. Cardi M, Muttillo IA, Amadori L, et al. Superiority of laparoscopy compared to ultrasonography 
in diagnosis of widespread liver diseases. Dig Dis Sci. 1997;42:546-548. 
13. Regev A, Berho M, Jeffers LJ, et al. Sampling error and intraobserver variation in liver biopsy 
in patients with chronic HCV infection. Am J Gastroenterol. 2002;97:2614-2618. 
14. Arase Y, Suzuki F, Suzuki Y, et al. Potential of laparoscopy in chronic liver disease with 320 
hepatitis B and C viruses. Hepatol Res. 2008;38:877-885. 
 Shoji et al. Laparoscopy of HBV to predict HCC  - 14 - 
15. Shiraki K, Shimizu A, Takase K, et al. Prospective study of laparoscopic findings with regard to 
the development of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis. 
Gastrointest Endosc. 2001;53:449-455. 
16. Shibayama T, Mori S, Ohtake H et al. Risk factors of hepatocellular carcinoma in chronic 325 
hepatitis C and cirrhosis: special reference to laparoscopic findings. Dig Endsc 1999;11:24-31.  
17. Desmet VJ, Gerber M, Hoofnagle JH, et al. Classification of chronic hepatitis: diagnosis, 
grading and staging. Hepatology 1994;19:1513-1520. 
18. Shimada N, Itoshima T, Ohta W, et al. A new classification of liver surface pictures by 
peritoneoscopic photography. Gastroenterol Endosc 1971;13:68-76. 330 
19. Watanabe M, Hirakawa H, Ikeda S, et al. Peritoneoscopy as an aid in intravenous injection of 
indocyanine green (ICG). Endoscopy 1985;17:149-152. 
20. Ito T, Itoshima T, Ukida M, et al. Peritoneoscopy of the liver stained by intravenous injection of 
indocyanine green-experimental and clinical studies. Gastroenterol Jpn. 1983;18:593-598. 
21. Michitaka K, Onji M, Horiike N, et al. Hepatitis B virus replication in dark reddish patchy 335 
markings appearing on the hepatic surface. Gastrointest Endosc. 1990;36:15-8. 
22. Kudo M. Imaging diagnosis of hepatocellular carcinoma and premalignant / borderline lesions. 
Semin Liver Dis. 1999;19:297-309. 
23. Peterson MS, Baron RL. Radiologic diagnosis of hepatocellular carcinoma. Clin Liver Dis. 
2001;5:123-144. 340 
24. Ohta W. Significance of reddish asteroidal and meshwork markings on the liver surface of 
chronic hepatitis observed by peritoneoscopy-observation of liver cell necrosis in relation to the portal 
and hepatic veins. Acta Hepato. Japan. 1975;16:448-463. 
25. Shibayama T, Ohtake H, Hishima T. Formation and clinical significance of reddish markings on 
the liver surface: activity of chronic liver disease. Dig Endosc 2003;15:100-107. 345 
26. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with 
chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet. 
1997;349:825-832. 
27. Al-Chalabi T, Boccato S, Portmann BC, et al. Autoimmune hepatitis (AIH) in the elderly: a 
systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at 350 
a tertiary referral centre. J Hepatol. 2006;45:575-583. 
 Shoji et al. Laparoscopy of HBV to predict HCC  - 15 - 
28. Kubota J, Ikeda F, Terada R, et al. Mortality rate of patients with asymptomatic primary biliary 
cirrhosis diagnosed at age 55 years or older is similar to that of the general population. J Gastroenterol. 
2009;44:1000-1006. 
29. Piao CY, Fujioka S, Iwasaki Y et al. Lamivudine treatment in patients with HBV-related 355 
hepatocellular carcinoma-using an untreated, matched control cohort. Acta Med. Okayama 2005; 59: 
217-224. 
30. Kuzuya T, Katano Y, Kumada T, et al. Efficacy of antiviral therapy with lamivudine after initial 
treatment for hepatitis B virus-related hepatocellular carcinoma. J. Gastroenterol. Hepatol. 
2007;22:1929-1935. 360 
31. Koda M, Matunaga Y, Kawakami M, et al. FibroIndex, a practical index for predicting significant 
fibrosis in patients with chronic hepatitis C. Hepatology 2007;23:297-306. 
32. Ngo Y, Benhamou Y, Thibault V, et al. An accurate definition of the status of inactive hepatitis B 
virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load. PLoS ONE. 
2008;3:e2573 365 
 
 Shoji et al. Laparoscopy of HBV to predict HCC  - 16 - 
Table 1: Laparoscopic evaluations of reddish markings and whitish markings. 
 
Item Definition Score 
Reddish markings   
Location Periportal 1 
 Pericentral 1 
 Multilobular 2 
Distribution Localized 1 
 Sparse 2 
 Dense 3 
Tone of color Indistinct 1 
 Common 2 
 Hemorrhagic 3 
Diagnostic classification   
  None  0 points 
  Mild reddish marking  <5 points 
  Severe reddish marking  ≥5 points 
   
Whitish markings   
Location Spotted 1 
 Asteroidal 2 
 Network-like 2 
Diagnostic classification   
  None  0 points 
  Mild whitish marking  <2 points 
  Severe whitish marking  ≥2 points 
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Table 2: Patient characteristics at the time of diagnosis. 370 
 
 (N = 303) 
Age at diagnosis (years) 34  11† 
Gender (female/male) 71/232 
Family history of liver disease 217 (71.6%) 
History of blood transfusion 14 (4.6%) 
Liver histology  
Fibrosis stage (1/2/3/4)* 92/90/101/20 
Activity grade (1/2/3)* 104/135/64 
Laboratory data at diagnosis  
AST (IU/L) 91  73† 
ALT (IU/L) 156  142† 
Total bilirubin (mg/dl) 0.87  0.53† 
Albumin (g/dl) 4.2  0.4† 
Platelet count (104/mm3) 18  6† 
 
* Histological stage classified by Desmet et al. (20); †: Mean  SD. 
AST, aspartate aminotransferase; ALT, alanine aminotransferase. 
 375 
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Table 3: Summary of laparoscopic features of HBV patients. 
 
 Surface irregularity* 
 S1 
(n=187) 
S2 
(n=93) 
S3 
(n=23) 
Reddish markings 89 (48%) 69 (74%) 15 (65%) 
Severe reddish markings 34 (18%) 34 (37%) 6 (26%) 
Whitish markings 51 (27%) 22 (24%) 3 (13%) 
Severe whitish markings 34 (18%) 12 (13%) 2 (9%) 
Vascular proliferation 160 (86%) 68 (73%) 20 (87%) 
Severe vascular proliferation 110 (59%) 57 (61%) 15 (65%) 
Patchy markings 28 (15%) 67 (72%) 2 (9%) 
Fat deposition 46 (25%) 25 (27%) 11 (48%) 
 
* Surface irregularity, classified in three stages: S1, normal or early stage; S2, advanced, pre-cirrhotic 
stage; and S3: cirrhotic stage. 380 
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Table 4: Analysis of factors predicting HCC development with the proportional hazards model. 
 
 Univariate analysis Multivariate analysis 
Factors Odds ratio (range†) p Odds ratio (range†) p 
Age at diagnosis (years) 1.06 (1.03-1.10) <0.001 1.06 (1.02-1.11) 0.002 
Gender (male) 3.32 (0.78-14.0) 0.10 4.53 (1.05-19.6) 0.043 
Blood transfusion 2.40 (0.56-10.2) 0.24   
Family history of liver disease 1.46 (0.67-3.18) 0.35   
Interferon therapy 0.65 (0.29-1.45) 0.29   
Histological fibrosis stage 1.80 (1.18-2.76) <0.001 1.21 (0.71-2.07) 0.49 
Histological activity grade 1.82 (1.06-3.14) 0.031 1.16 (0.58-2.34) 0.68 
AST (80 IU/L) 1.32 (0.62-2.83) 0.47   
ALT (80 IU/L) 1.06 (0.48-2.37) 0.88   
Surface irregularity 2.45 (1.46-4.09) <0.001   
Whitish markings 0.77 (0.31-1.90) 0.57   
Vascular proliferation 1.27 (0.48-3.36) 0.64   
Reddish markings 1.66 (1.04-2.65) 0.036 1.45 (0.54-3.90) 0.46 
Patchy markings 2.04 (0.96-4.36) 0.065 1.38 (0.57-3.32) 0.48 
Fat deposition 1.28 (0.48-3.37) 0.62   
 
†: 95% confidence interval; AST, aspartate aminotransferase; ALT, alanine aminotransferase. 
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Table 5: Analysis of factors predicting HCC development for patients with age 30 years with 
the proportional hazards model. 
 
 Univariate analysis 
Factors Odds ratio (range†) p 
Histological fibrosis stage 1.57 (1.02-2.40) 0.04 
Histological activity grade 1.67 (0.95-2.95) 0.075 
AST (80 IU/L) 0.72 (0.33-1.57) 0.41 
ALT (80 IU/L) 1.18 (0.53-2.66) 0.69 
Surface irregularity 1.93 (1.13-3.31) 0.016 
Reddish markings 1.67 (1.04-2.70) 0.034 
Patchy markings 1.54 (0.68-3.48) 0.30 
 
†: 95% confidence interval; AST, aspartate aminotransferase; ALT, alanine aminotransferase. 390 
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FIGURE LEGENDS 
Figure 1: Laparoscopic features of the patients with chronic viral hepatitis. 
Figures show typical pictures of laparoscopic features; laparoscopy of severe reddish markings, 
showing advanced surface irregularity with densely distributed reddish markings (a), closer view of 395 
severe reddish markings in hemorrhagic color which are multilobularly located (b), closer view of mild 
reddish markings, showing common redness in periportal areas (c), laparoscopy of vascular 
proliferation (d), and laparoscopy of normal liver (e). 
 
Figure 2: Comparisons of histology, laboratory parameters, and laparoscopic findings. 400 
Histological fibrosis stage was compared with total scores of the five conventional parameters related 
to liver function with significant correlations (R=0.46, P<0.0001, canonical correlation analysis, Fig 2a): 
fibrosis stage 1, striped; stage 2, open; stage 3, gray; and stage 4, black. Significantly high correlations 
were also shown between histological fibrosis stage and laparoscopic surface irregularity (R=0.66, 
P<0.0001, Fig 2c): fibrosis stage 1, striped; stage 2, open; stage 3, gray; and stage 4, black. As for the 405 
activity, alanine aminotransferase (ALT) levels were divided in 4 groups and compared with histological 
activity grade, showing significant associations (R=0.14, P=0.013, Fig 2b): A1, open; A2, gray; A3, 
black. Correlations between histological activity grade and reddish markings were significant as shown 
in Fig 2d (R=0.45, P<0.0001): A1, open; A2, gray; and A3, black.  
 410 
Figure 3: Cumulative rates of hepatocellular carcinoma (HCC) development. 
Fig. 3a shows cumulative rate of HCC development as the follow-up period, estimated by the 
Kaplan-Meier method, The incidence of HCC development was estimated as 5.7% at 5 years of 
follow-up, 13.5% at 10 years, and 20.6% at 15 years. Fig. 3b shows cumulative rates of HCC 
development by age, estimated as 1.3% at 40 years old, 12.3% at 50 years old, and 27.2% at 60 years 415 
old. When the patients were divided in three groups according to age at diagnosis (<30 years, 31-39 
years, and 40 years), there were significant differences in cumulative rates of HCC development 
among the groups (p=0.003, log-rank test, Fig. 3c). Furthermore, Fig 3d shows significant difference in 
cumulative rates of HCC development between the female patients and the male patients (p=0.008, 
log-rank test). 420 
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Figure 4: Cumulative rates of hepatocellular carcinoma (HCC) development, stratified by histology and 
laparoscopic findings. 
Figures show cumulative rates of HCC development estimated by the Kaplan-Meier method, stratified 
by histological fibrosis stage (a), laparoscopic surface irregularity (b), histological activity grade (c), and 425 
laparoscopic reddish markings (d). Significant associations with HCC development were shown for 
liver cirrhosis according to histological fibrosis (p=0.030, log-rank test) and laparoscopic surface 
irregularity (p=0.002). Severity of laparoscopic reddish markings was significantly associated with HCC 
development (p=0.036), while that of histological activity grade was not (p=0.054, log-rank test).  
 430 
Figure 5: Cumulative rates of hepatocellular carcinoma (HCC) development, for the patients of age  
30 years at diagnosis, stratified by disease progression. 
Figures show cumulative rates of HCC development, for the patients of age  30 years at diagnosis, 
stratified by histological fibrosis stage (Fig. 5a) and surface irregularity (Fig. 5b and 5c). Cumulative 
rates of HCC development were significantly higher in more advanced diseases, according to surface 435 
irregularity (Fig. 5b, P=0.043, log-rank test), but not to histological fibrosis stage (Fig. 5a, P=0.19). The 
risk of HCC development was significantly higher among the patients of age 30 years even in 
laparoscopic S1 stage at diagnosis, compared with the patients of age <30 years (Fig. 5c, P=0.031, 
log-rank test).  
 440 
Figure 6: Cumulative rates of hepatocellular carcinoma (HCC) development, for the patients of age  
30 years at diagnosis, stratified by inflammatory activity. 
Cumulative rates of HCC development are shown for patients of age  30 years at diagnosis, stratified 
by histological activity (a), laparoscopic Reddish markings (b), and ALT levels (c). Cumulative rates of 
HCC development showed significant differences when stratified by reddish markings (P=0.025, 445 
log-rank test), but not by histological activity (P=0.087) or ALT levels (P=0.69).  
 
